“With Medicare being the single largest payer of health care services in the U.S., coverage and payment decisions can have far reaching implications to the success of life science companies,” said Debra Bowes, WIB President. “Whether, and how much, Medicare will pay determines if a project moves forward or is adopted by a larger partner or venture capital. It is therefore critical for organizations to understand coverage and reimbursement at the start of their efforts. Our panel of experts will help guide attendees through these processes while also providing a great networking platform for women in life sciences.”
The event’s panel includes a top government expert, Tamara Syrek Jensen, JD, Deputy Director, Coverage and Analysis Group, Centers for Medicare & Medicaid Services (CMS), U.S. Dept of Health & Human Services; and industry leaders Rachel King, MBA, CEO and founder, GlycoMimetics, Inc.; Sara Nayeem, MD, MBA, Principal, New Enterprise Associates (NEA); and Caroline York, Reimbursement Account Manager, Auxilium Pharmaceuticals, Inc.
To register, please visit the Women in Bio website.
About Women In Bio: Women In Bio (WIB) is a non-profit organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences. Established in 2001, WIB aims to serve all women in the bioscience industry, now with chapters across the U.S. WIB conducts professional development programs, workshops, and seminars; organizes networking opportunities with investors, attorneys, researchers and executives in fields such as finance, marketing, human resources, and communications; and holds social events. Other initiatives include the inspiring Young Women In Bio (YWIB) program and a scholarship fund honoring WIB co-founder Robbie Melton. Women In Bio is funded in part by its 2011 National Sponsors: the Biotechnology Industry Organization and WilmerHale. To learn more, visit http://www.womeninbio.org/.
Contact: Michelle Chiodo 773-332-7380 mchiodo@acrxs.com
